Drugs / JE-CV Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01190228 | Aug → Oct 2010 | Japanese encephalitis, chickenpox | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JE-CV Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01190228 ↗ |
| Modality | Vaccine | “Japanese Encephalitis Chimeric Virus Vaccine (JE-CV)” NCT01190228 ↗ |
| Route | Subcutaneous | “0.5 mL (single dose), Subcutaneous” NCT01190228 ↗ |